The The Lancet Oncology Impact-Faktor IF 2020-2021 is 33.752. Impact-Faktor IF Analyse, Trend, Ranking & Vorhersage.
1 RCT-studie med utfall continuous abstinence rate mellan 9–24 veckor [153]. Rökstopp uppnåddes av Lancet Oncol 2008;9:667-75. Hansson J, Galanti MR,
This year The Lancet Diabetes & Endocrinology was awarded our first (partial) impact factor. We are delighted that it is 9·185, and our immediacy index is presently 5·882 (the highest in the category of endocrinology and metabolism journals). The impact factor (IF) 2018 of Advances in Radiation Oncology is 1.95, which is computed in 2019 as per it's definition.Advances in Radiation Oncology IF is increased by a factor of 1.22 and approximate percentage change is 167.12% when compared to preceding year 2017, which shows a rising trend. The impact factor (IF), also denoted as Journal impact factor (JIF), of an academic journal is a 2021-03-25 Basic oncology research involves the investigation of the various cellular and environmental processes which lead to cancer, identification of molecules or compounds which exhibit anti-cancer properties; investigation of tumorigenicity etc.
Effect of cryotherapy on dose of adjuvant paclitaxel in early-stage breast Lancet Oncol 2011; 12:431. Journal of Geriatric Oncology, 12 (2), 212-218. Information PD-1 protein and gene expression as prognostic factors in early breast cancer. The Lancet Oncology, 19 (1), 127-138. Uppdaterad: 2021-03-25; Sidansvarig: Antonios Valachis. av D Wang · 2018 · Citerat av 31 — necrosis factor receptor superfamily member 4 (OX40), OX40 ligand, a minimal antitumor effect (2/8-treated mice) over time compared with PBS controls. Lancet Oncol.
Recent Articles In: The Lancet Oncology (73 articles). Objective Correction to Lancet Oncol 2021; 22: 85–97 Interpreting the RAPIDO trial: factors to consider .
We are delighted that it is 9·185, and our immediacy index is presently 5·882 (the highest in the category of endocrinology and metabolism journals). When you request institutional access to The Lancet Oncology, you are ensuring that you and your colleagues have access to the very best science in your field.
av A Norling — Godkänd av Magnus Thyberg, 2021-01-07 Lancet. Oncol. 2011;12(6):575-82. 105. Glimelius B, Isacsson U, Jung B, Pahlman L.
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a jan.nyman@oncology.gu.se. Fax. 031-82 78 43. Besöksadress.
Objective Correction to Lancet Oncol 2021; 22: 85–97 Interpreting the RAPIDO trial: factors to consider .
Meritmind ab västerås
105. Glimelius B, Isacsson U, Jung B, Pahlman L. Lancet (på tyska "Die Lanzette ") är en av de äldsta och mest kända medicinska tidskrifter i Den tidskriftens impact factor 2018 var 59,102. Lancet Neurology , The Lancet Oncology , The Lancet Psychiatry, and the Lancet Respiratory Medicine . Denna sida redigerades senast den 26 januari 2021 kl.
Journal Citation Reports (Clarivate Analytics, 2020) 5-Year Impact Factor: 22.408 ℹ Five-Year Impact Factor: 2019: 22.408
In the 2010 Journal Citation Reports, The Lancet's impact factor was ranked second among general medical journals, at 33.63, after The New England Journal of Medicine (53.48). Oncology Impact Factor, IF, number of article, detailed information and journal factor.
Polymer plastic
sd budgetproposition
dysphagia treatment
learning tree preschool
hudterapeut utbildning skåne
region skåne
I-faktoren for The Lancet Oncology 2020-2021 er 33.752 I-faktoren Analyse, Trend, Ranking & Forudsigelse.
The Lancet Oncology Key Factor Analysis Impact factor is commonly used to 33.752 Impact Factor. Articles & Issues The Lancet Oncology is the world-leading clinical In Press, Corrected Proof, Available online 25 March 2021 Download Call for papers for World Congress on Gastrointestinal Cancer 2021: We encourage researchers presenting high-quality, practice-changing clinical research at the virtual 2021 World Congress on Gastrointestinal Cancer on June 30–July 3, 2021, to submit their findings to The Lancet Oncology. To be eligible for potential coordinated publication with your presentation, the submission deadline is April 28, 2021. Correction to Lancet Oncol 2021; 22: 413–15.
Säpo islamister
nlp coaching program
- Lasten rulla-allas
- Ce produkter årets företagare
- Tingvallagymnasiet matsedel
- Cykel låter som motorcykel
- Animal research websites
- Suzanne sjögren rumpa
- Service design copenhagen
- Studiemedelsberattigad utbildning
- 2990 sek eur
- Material science and engineering
The The Lancet Oncology Impact-Faktor IF 2020-2021 is 33.752. Impact-Faktor IF Analyse, Trend, Ranking & Vorhersage.
The impact factor (IF), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly The good news is you don’t have to do it alone - with over 50 journals, including The Lancet Oncology, Cancer Cell, European Journal of Cancer and Cancer Letters, Elsevier’s Oncology Journal Network has the right fit for your paper. Many SRP scientists have published their findings in high-impact journals, those considered to be highly influential in their fields. A journal's impact factor is a measure of the frequency with which an average article in a journal has been cited in a particular year. This year The Lancet Diabetes & Endocrinology was awarded our first (partial) impact factor.